# Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

> **NCT06226415** · NA · COMPLETED · sponsor: **Zeng Changhao** · enrollment: 84 (actual)

## Conditions studied

- Cerebral Small Vessel Diseases

## Interventions

- **BEHAVIORAL:** Rehabilitation therapy
- **PROCEDURE:** Stellate ganglion block
- **DRUG:** Lidocaine Hydrochloride

## Key facts

- **NCT ID:** NCT06226415
- **Lead sponsor:** Zeng Changhao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-20
- **Primary completion:** 2024-05-25
- **Final completion:** 2024-06-01
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06226415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06226415, "Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06226415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*